54 filings
15-12G
RYZB
RayzeBio Inc.
7 Mar 24
Securities registration termination
4:07pm
S-8 POS
RYZB
RayzeBio Inc.
26 Feb 24
Registration of securities for employees (post-effective amendment)
9:20am
8-K
RYZB
RayzeBio Inc.
26 Feb 24
Termination of a Material Definitive Agreement
9:20am
25-NSE
RYZB
RayzeBio Inc.
26 Feb 24
Exchange delisting
8:55am
SC 14D9/A
RYZB
RayzeBio Inc.
23 Feb 24
Tender offer solicitation (amended)
7:53am
SC TO-T/A
6gil8m26ex
23 Feb 24
Third party tender offer statement (amended)
7:34am
SC TO-T/A
xn89j4boet4
16 Feb 24
Third party tender offer statement (amended)
11:36am
SC 14D9/A
uiw0yzfgeky
14 Feb 24
Tender offer solicitation (amended)
9:19am
SC 14D9/A
713r7kc xs
12 Feb 24
Tender offer solicitation (amended)
8:54am
SC TO-T/A
j4o46yd 5nuh72rjztou
12 Feb 24
Third party tender offer statement (amended)
7:34am
SC 14D9
3owu8chbmiuhw
25 Jan 24
Tender offer solicitation
8:53am
SC TO-T
v1eg151p2k4l
25 Jan 24
Third party tender offer statement
8:13am
SC14D9C
ebvcr
27 Dec 23
Written communication relating to third party tender offer
4:15pm
SC14D9C
t68z amxsphxzce8325
26 Dec 23
Written communication relating to third party tender offer
5:08pm
SC TO-C
9rjen
26 Dec 23
Information about tender offer
4:22pm
SC14D9C
b8r7lfvg
26 Dec 23
Written communication relating to third party tender offer
8:32am
8-K
8d1ub6bakq57g2s
26 Dec 23
Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
8:26am
10-Q
w3gf6 js6t1
13 Nov 23
Quarterly report
4:04pm
8-K
nri00klu5gz 5e9xzx
13 Nov 23
RayzeBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:03pm
8-K
3xg770 8o
1 Nov 23
Departure of Directors or Certain Officers
9:14am